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Abstract The abuse of synthetic esters of natural steroids
such as testosterone and estradiol in cattle fattening and
sports is hard to detect via routine urine testing. The esters
are rapidly hydrolysed in vivo into substances which are
also endogenously present in urine. An interesting alterna-
tive can be provided by the analysis of the administered
synthetic steroids themselves, i.e., the analysis of intact
steroid esters in hair by liquid chromatography tandem
mass spectrometry (LC/MS/MS). However, retrospective
estimation of the application date following a non-
compliant finding is hindered by the complexity of the
kinetics of the incorporation of steroid esters in hair. In this
study, the incorporation of intact steroid esters in hair
following pour-on treatment has been studied and critically
compared with results from intramuscular treatment. To this
end animals were pour-on treated with a hormone cocktail
containing testosterone cypionate, testosterone decanoate
and estradiol benzoate in different carriers. The animals
were either treated using injection and pour-on application
once or three times having 1 week between treatments
using injection and pour-on application. Animals were
slaughtered from 10–12 weeks after the last treatment. Both
hair and blood plasma samples were collected and analysed
by LC/MS/MS. From the results, it is concluded that after
single treatment the levels of steroid esters in hair drop to
CCβ levels (5–20 µg/kg) after 5–7 weeks. When treatment
is repeated two times, the CCβ levels are reached after 9–
11 weeks. Furthermore, in plasma, no steroid esters were
detected; not even at the low microgramme per litre level
but—in contrast with the pour-on application—after i.m.
injection, significant increase of 17β-testosterone and 17β-
estradiol were observed. These observations suggest that
transport of steroid esters after pour-on application is not
only performed by blood but also by alternative fluids in
the animal so probably the steroid esters are already
hydrolysed and epimerized before entering the blood.
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Introduction
Anabolic steroids are banned substances in the European
Union but might still be illegally applied as growth
promoters in cattle fattening [1, 2]. In the search for suitable
sample matrices, bovine hair has shown to be an attractive
sample matrix for prolonged detectability of residues of
anabolic steroids and beta-agonists. Such substances can be
incorporated into hair from blood via the hair follicle,
incorporated from sweat via the hair shaft, absorbed from
sweat on the outside of the hair shaft, and/or absorbed from
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exogenic sources such as (environmental) contamination or
intentional illegal pour-on treatment [3–6]. The potential of
hair analysis for the determination of steroids and beta-
agonists has been demonstrated in several papers [5, 7–18].
Natural steroids are usually administered as synthetic steroid
esters but these are rapidly hydrolysed in vivo into natural
steroids: following oral intake of testosterone undecanoate,
the unchanged ester could be found in plasma from athletes
for 6 h only [19]. In urine, it is hard to differentiate between
the (metabolites of) endogenous natural steroids always
present and the identical (metabolites of) natural steroids
from the hydrolysed esters. In doping control, this problem
is usually addressed by establishing the 17β-testosterone/
17α-testosterone urinary ratio (so-called T/E ratio) [20]
and/or the application of 13C/12C isotope ratio mass
spectrometry [21]. In food surveillance, relatively high or
low findings of 17β-testosterone and 17α-testosterone in
urine are often ignored because of the lack of statistically
valid reference data of naturally occurring background
levels. An interesting alternative for inconclusive urine
analyses in veterinary control can be provided by the
analysis of the administered synthetic steroids themselves,
i.e. the analysis of intact esters of natural steroids in hair.
Gleixner and Meyer digested hair samples using dithio-
threitol to break up the longitudinal chains of the keratin
protein of the hair by reducing the disulfide bonds and
applied that method to the determination of the natural
steroids estradiol and testosterone [10]. Hooijerink et al.
developed an LC/MS/MS method for the determination of
intact estradiol benzoate in hair using the reducing agent
tris(2-carboxyethyl)phosphine hydrochloride (TCEP) [22].
Meanwhile, that method has been further developed
towards a true multiresidue screening method for all kinds
of intact esters of testosterone, boldenone and estradiol [23]
and adopted by other countries as well [24]. Thanks to this
method, several cases of illegal use of synthetic esters of
natural steroids were discovered in recent years.
Following a non-compliant finding of a synthetic ester of a
natural steroid in hair, questions arise regarding a retrospec-
tive estimation of the date of illegal application might arise. In
general, there will be no simple answers to that. When no
preparations have been found, the route of administration
remains unknown and might comprise injection, oral,
sublingual, pour-on or other means. Moreover, several papers
studying hair segments reported the lack of correlation
between incorporation time and growth rate of hair [25–27].
This discrepancy is believed to be due to the fact that steroid
esters are mainly incorporated via sweat and sebum
excretion at the surface of the skin followed by diffusion
into the hair fibre [25]. Apart from that, interindividual
differences in metabolisation rates do occur of course.
Data about detectability in hair following pour-on
application are rare. Anielski et al. [28] investigated a
NorAndrosteDerm application containing prohormones of
nortestosterone but intact esters were not studied.
Hooijerink et al. [22] reported estradiol benzoate concen-
trations up to 8500 ng g−1 in bovine hair following pour-on
application. Thieme et al. [6] compared transdermal and
oral application of anabolic steroids and concluded that
effective and durable concentrations of active steroids in
blood could be obtained following the former treatment.
This study was designed to test the hypothesis whether
the incorporation of intact steroid esters into bovine hair
following pour-on treatment is detectable. The findings
were critically compared with results from intramuscular
treatment. To this end, animals were pour-on treated with a
typical hormone cocktail containing testosterone cypionate,
testosterone decanoate and estradiol benzoate in different
carriers, or by intramuscular injection. Hair and blood
samples were collected during several weeks and analysed
for intact steroid esters by state of the art LC/MS/MS. Hair
samples were taken by using a razor. The possibility of
carry-over by using one razor to shave different animals
was investigated as well.
Experimental
Chemicals, reagents and solutions
LC-C/MS-grade acetonitrile, water and methanol were
obtained from Biosolve (Valkenswaard, the Netherlands).
Formic acid, acetone, acetonitrile, ethanol, n-pentane, iso-
octane, dithiothreitol and Tris(hydroxymethyl)-amino-
methane were obtained from Merck (Darmstadt, Germany).
The reduction agent tris(2-carboxyethyl) phosphine hydro-
chloride (TCEP) was obtained from Sigma (St. Louis, MO,
USA). Estradiol benzoate (EB), testosterone cypionate (TC)
and testosterone decanoate (TD) were obtained from
Sigma-Aldrich Chemie b.v (Zwijndrecht, the Netherlands).
N-methyl-N-trimethylsilyl-trifluoro(o)acetamide (MSTFA)
was obtained from Alltech (Anaconda, Montana, USA),
ammonium iodide was obtained from Fluka (Zwijndrecht,
the Netherlands). The steroids 17α-testosterone and 17β-
testosterone were obtained from Steraloids (Newport,
Rhode Island, US). 17α-Estradiol was obtained from
Diosynth (Morrisville, North Carolina, US), 17β-estradiol
was obtained from Organon (Oss, the Netherlands) and the
internal standards 17β-testosterone-d2 and 17β-estradiol-
d3 were obtained from RIVM (Bilthoven, the Netherlands).
The deuterium-labelled internal standards d3-estradiol
benzoate, d3-testosterone cypionate and d3-testosterone
decanoate were in-house-synthesised as described in [23].
The carrier solvents for pour-on application Ivomec®
(mixture of isopropanol and Ivermectin B1a, B1b), DMSO
(dimethyl sulfoxide Ph Eur), Mygliol® 840 (Triglycerida
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saturate media Ph Eur), DEGMBE (diethyleneglycol
monobutyl ether) and the carrier for injection Arachide oil
were obtained from Spruyt Hillen b.v. (IJsselstein, the
Netherlands). All other chemicals used were of analytical-
reagent grade.
The derivatization reagent MSTFA++ for the free steroid
analysis consisted of N-methyl-N-trimethylsilyl-trifluoro(o)
acetamide/ammonium jodide/dithiothreitol (1,000/2/4; v/w/w).
Individual stock solutions of the steroid esters were prepared
by dissolving 10 mg of each compound in 10 ml of methanol.
Individual stock solutions of the steroids were prepared by
dissolving 10 mg of each compound in 10 ml of ethanol.
Solid-phase extraction columns type Bond Elute LRC-C18
Phase 100 mg and 500 mg columns were obtained from
Varian (Harbor City, CA, USA).
Equipment
The separation of the steroid esters was carried out using an
ultra performance liquid chromatographic (UPLC) system,
consisting of vacuum degasser, autosampler and a binary
pump (Acquity UPLC system; Waters, Milford, MA)
equipped with a reversed phase Waters acquity UPLC
BEH C18 analytical column of 100×2.1 mm and 1.7 µm
particle size. The gradient (solvent A, water–acetonitrile–
methanol–formic acid (300:350:350:20, v/v/v/v); solvent B,
acetonitrile–methanol–formic acid (500:500:20, v/v/v)) was:
0 min, 0% B; 0.5–6 min, linear increase to 100% B; 6–
7.5 min 100% B. Injection volume was 40 µl. The UPLC
system was connected to a triple-quadrupole mass spec-
trometer model Quattro Premier (Waters, Manchester, UK)
equipped with an electrospray interface operating in the
positive ion mode. The MRM transitions acquired for the
different steroid esters of interest are summarised in Table 1.
The free steroids 17α-, 17β-estradiol and 17α-, 17β-
testosterone were analysed by using GC-MS/MS. A Varian
(Palo Alto, California, US) 1,200 L triple-quadrupole MS/
MS spectrometer equipped with a CP8400 autosampler and
CP-3800 GC was used. The GC column was a VF-17MS
(L=30 m, id=0.25 mm, df=0.25 µm) obtained from Varian.
The temperature programme used started at 110 °C (hold
1 min); increased at 20 °C/min to 240 °C (hold 1.5 min);
increased with 1 °C /min to 243 °C followed by an increase
of 25 °C/min to a final temperature of 340 °C (hold 2 min).
The GC-MS/MS was operated in the EI ionisation mode.
The MRM transitions acquired for the different steroids of
interest are summarised in Table 2.
Samples
An animal trial has been conducted at the Physiology
Weihenstephan, Technical University of Münich (Ger-
many). The protocol has been approved by the ethical
committee of the ‘Regierung von Oberbayern’. Twenty veal
calves (Holstein–Friesian) were obtained from identified
sources at an age of 2 weeks. The animals were housed on
straw and the different treatment groups were housed in
separate pens. The animals were fed according to veal calf
practise, using milk replacer and roughage, drinking water
was ad lib.
Pour-on experiments were carried out using hormone
cocktails containing three steroid esters. Prior to application
the animals were shaven on the back from neck to tail.
There, they were treated with 10 ml pour-on cocktail. In
total, a set of four pour-on hormone cocktails were prepared
and for each cocktail, a different carrier solvent was used.
The hormone cocktails contained 25 mg of EB, 60 mg of
TD and 60 mg of TC per 10 ml of carrier solvent. The
carrier solvents used were Ivomec, DMSO, Mygliol 840
and DEGMBE.
Table 3 presents the application scheme. Five animals
were not treated at all and were used as reference group.
Four animals were treated at day 1, 7 and 14 (repeated
treatment) with 10 ml of carrier solvent. Four animals were
treated at day 1 with 10 ml of hormone cocktail; each
animal was treated with a different carrier solvent. Four
animals were treated on day 1, 7 and 14 (repeated
treatment) with 10 ml of hormone cocktail. One animal
was injected intramuscular in the neck on day 1 with a
cocktail of 35 mg EB, 60 mg TD and 60 mg TC and one
Table 1 Steroid esters; specific ions monitored for LC-ESI(+)-MS/MS
Compound MRM transition 1
(m/z)
Collision energy MRM
transition 1 (eV)
MRM transition 2
(m/z)
Collision energy
MRM transition 2
Rt in
min
Estradiol benzoate 377>105 40 377>77 45 3.64
Estradiol benzoate-d3 380>105 20 3.63
Testosterone cypionate 413>97 25 413>107 25 5.46
Testosterone cypionate-d3 416>97 25 5.45
Testosterone decanoate 443>97 25 443>109 30 6.53
Testosterone decanoate-d3 446>97 25 6.53
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animal was injected on day 1, 7 and 14 with the hormone
cocktail. For the injection, arachide oil was used as the
carrier. One animal was injected three times (day 1, 7 and
14) with arachide oil.
For pour-on application, the liquid-containing steroid
esters (hormone cocktail) were spread out over the small
(shaved) strip at the back of the animal from neck to tail.
Hair samples were taken at least 20 cm off from the
application zone. The first hair samples were taken before
treatment. After 1 week (7 days) the second hair sample
was taken at the next spot (see Fig. 1). The samples taken
35 days after treatment are taken at the same spot as the
sample which was taken at day 1. Table 4 and Fig. 1
describe the ‘hair sampling scheme’ including the spots
where the samples are taken, the number of days after first
treatment and the weeks the hair had been growing at the
specific spot. Each sample contained approximately 2–5 g
of hair.
Hair samples were taken by using one razor but with one
shaver head for each treatment group. To check for carry-
over from one hair sample to the other due to the use of only
one razor system, a contamination experiment was per-
formed. The (worst case) contamination experiment was as
follows: a piece of skin was treated (pour-on) using the
steroid cocktail. The hair directly on the pour-on spot was
collected by using a razor. The razor was cleaned dry by
carefully removing the hair and blowing some air through
the razor. No visible pieces of hair were left. The same razor
was used to shave an untreated piece of skin. This hair
sample was tested for containing residues of steroids esters.
Samples of blood were taken at days 1, 2, 3, 4, 5, 6, 7,
14, 21, 28, 42, 56, 70, 84 and 98. The samples were taken
Table 2 Free steroids; specific ions monitored for GC-EI-MS/MS
Compound MRM transition 1
(m/z)
Collision energy MRM
transition 1 (eV)
MRM transition 2
(m/z)
Collision energy
MRM transition 2
17α-estradiol 416>326 −7.5 416>285 −10.0
17β-estradiol 416>326 −7.5 416>285 −10.0
17β-estradiol-d3 419>285 −10.0
17α-testosterone 432>327 −15.0 432>209 −12.5
17β-testosterone 432>301 −15.0 432>209 −12.5
17β-testosterone-d2 434>211 −12.5
Table 3 Application scheme
Animal group Day of
treatment
Animal id no. Type of treatment
Reference group (n=5 animals) – 175, 182, 185, 191, 193 No treatment
Reference group treated (3 times)
with carrier solvents only
Day 1, 7 and 14 172 Injection with Arachide oil
173 Pour-on with carrier solvent DEGMBE
177 Pour-on with carrier solvent DMSO
181 Pour-on with carrier solvent IVOMEC
184 Pour-on with carrier solvent Miglyol
Treated once Day 1 174 i.m. injection with hormone cocktaila
178 Pour-on hormone cocktail in DEGMBE
180 Pour-on hormone cocktail in DMSO
183 Pour-on hormone cocktail in IVOMEC
188 Pour-on hormone cocktail in Miglyol
Treated three times Day 1, 7 and 14 171 i.m. injection with hormone cocktail
179 Pour-on hormone cocktail in DEGMBE
187 Pour-on hormone cocktail in DMSO
190 Pour-on hormone cocktail in IVOMEC
192 Pour-on hormone cocktail in Miglyol
a Hormone cocktail contents 25 mg of estradiol benzoate, 60 mg of testosterone decanoate and 60 mg of testosterone cypionate for each injection
or for each 10 ml of carrier solvent
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before each animal treatment. Blood samples were collected
in EDTA Vacutainer, centrifuged and the plasma was used
for the analysis. Hair and blood samples were stored at
−20 °C.
Methods
Analysis of steroid esters in hair
Hair steroid esters The samples were treated as described
in details by Nielen et al. [23] with some minor changes.
The hair samples were analysed without using a washing
step. Normally, the washing step with water is to wash
away mud, etc. The samples were very clean so the
washing step was omitted. In short, the procedure is as
follows: the hair samples were cut into 0.5 cm pieces using
a pair of scissors. Then, 500 mg was pulverised using a
Mikro-dismembrator S ball mill. Two hundred milli-
grammes of the pulverised hair was weighed into a plastic
tube and deuterium-labelled internal standards were added
(10 ng/g hair). Digestion of the hair was performed by
addition of 2 ml of 25 mM TCEP and incubation at room
temperature for 1 h. The tube was shaken by using a ‘head-
over-head’ shaker. After addition of 4 ml of methanol, the
tube was centrifuged for 5 min at 1,700×g. Next, 4 ml of
water was added and the mixture was applied to an
activated C18 solid-phase extraction (SPE) column. The
SPE column was conditioned by the addition of, respec-
tively, acetonitrile, methanol and water. The column was
washed with 2 ml of methanol/water (60/40, v/v) and eluted
with 2 ml acetonitrile followed by 2 ml of ethyl acetate.
The SPE eluate was evaporated to dryness under a gentle
steam of nitrogen gas at 40 °C and redissolved in 200 µl of
LC solvent A, water–acetonitrile–methanol–formic acid
(300:350:350:20, v/v/v/v). Finally, 40 µl was analysed by
UPLC-MS/MS. For each steroid ester, two transitions (see
Table 1) were monitored and for each deuterium-labelled
analogue one transition was measured. The response factor
was defined as the ratio between the sum of peak areas of
the steroid ester transitions and the peak area of the
transitions of the deuterium-labelled analogue.
For quantification, response factors versus concentration
plots were constructed. To this end, seven blank hair
samples were fortified with different concentrations of the
steroid esters. The concentration of TC, TD ranged from 10
to 1,000 µg/kg and the concentration of EB from 2.5 to
250 µg/kg. The concentrations of the deuterium-labelled
analogues were 50, 100 and 100 µg/kg for each sample of
EB, TC and TD, respectively. The hair samples were
analysed together with the calibration samples (Matrix
Application side 
Application side 
Spot 1(=6=11) 
Spot 4 
(=9=14)
Spot 3 
(=8=13)
Spot 2(=7=12) 
Spot 5 
(=10=15)
Fig. 1 Spots were the hair samples are taken (see also Table 4)
Table 4 Sampling scheme for hair samples (see also Fig. 1)
Spot Days after first treatment Weeks of grown hair
1 0 (before treatment) 8
2 7 9
3 14 10
4 21 11
5 28 12
6 (=1) 35 5
7 (=2) 42 5
8 (=3) 49 5
9 (=4) 56 5
10 (=5) 63 5
11 (=1=6) 70 5
12 (=2=7) 77 5
13 (=3=8) 84 5
14 (=4=9) 91 5
15 (=5=10) 98 5
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Match Standards; MMS); concentrations were calculated
using the linear regression method.
Analysis of steroid esters in plasma
The analysis of steroid esters in plasma was set up for this
study and was based on the procedure described by
Shackleton et al. [29]. To 1 ml of plasma, 5 ng of each
internal standards and 4 ml of acetone/ethanol (1/1; v/v)
were added. After intensive shaking and after centrifuga-
tion, the supernatant was transferred to a clean tube and the
solvent was evaporated at 40 °C under a gentle stream of
nitrogen. The residue was redissolved in 4 ml of methanol
and 6 ml of water. The complete extract of 10 ml was
applied to a preconditioned SPE column. The SPE
procedure and the LC-MS/MS procedure were as described
for the analysis of steroid esters in hair section. Because of
the expected low concentrations of steroid esters in plasma
the concentration range used for the calibration curve was
0–10 µg/l.
Analysis of the free steroids 17α-, 17β-estradiol
and 17α-, 17β-testosterone in plasma
The samples were treated as described by van Tricht et al.
[30]. In short, the procedure is as follows: to 1 ml of
plasma, 0.5 ng of each internal standard and 1 ml methanol
were added. The proteins were denaturated and after
addition of 1 ml of water, the mixture was applied to a
C18 SPE column. The SPE was preconditioned with 3 ml
of methanol and 3 ml of water. After a washing step with
water and acetonitrile/water (35/65; v/v) the analytes of
interest were eluted with 3 ml of acetone. The eluate was
collected and evaporated at 50 °C under a gentle stream of
nitrogen and redissolved in 100 µl of methanol and 2 ml of
Tris-buffer pH 9.5. Liquid–liquid extraction (LLE) was
performed with 7 ml of n-pentane. This extraction step was
repeated and the organic layers were collected and
evaporated (see above). The residue was redissolved in
0.5 ml of ethanol and transferred into a derivatisation vial
and the ethanol was evaporated. The dry residue was
derivatised by adding 25 µl of MSFTFA++ followed by
incubation of 1 hour at 60 °C. The derivatised mixture was
evaporated and the residue was reconstituted in 25 µl of
iso-octane; 4 µl was injected into the GC-MS/MS (pulse
pressure 30 psi). The ion ratio was defined as the ratio
between the area of the MS-MS transition 1 (see Table 2) of
the steroid and the deuterium-labelled analogue. For 17α-
estradiol and 17α-testosterone, the 17β- deuterium-labelled
analogues were used. For quantification, ion ratios versus
concentration plots were constructed. For quality control,
five blank plasma samples were fortified with different
concentrations of the steroid. The concentration of steroids
ranged from 0 to 0.4 µg/l. The concentrations of the
deuterium-labelled analogues were 0.2 µg/l for each
sample. The plasma samples and quality control samples
were analysed together with the calibration standards;
concentrations were calculated using the linear regression
method.
Results and discussion
There is not much information available regarding the
pharmacokinetics of steroid esters administered to an
animal by ‘pour-on’ application [26]. Therefore, it is of
interest to know if the steroid esters finally reach the
bloodstream. To collect information about the distribution
of the steroid esters it was decided to analyse a selection of
the plasma samples for containing steroid esters (EB, TC
and TC). From literature, it is known [29] that after
injection of steroid esters, the esters are hydrolysed and
the free steroids are detected in the blood. To find out if the
free steroid (17α-, 17β-estradiol and 17α-, 17β-
testosterone) concentration in plasma also increases after
‘pour-on’ application, the free steroid concentration was
measured in a sub selection of the plasma samples. The
results of the analysis of hair samples and plasma samples
are described below.
Determination of steroid esters in hair samples
by LC-MS/MS
LC-MS/MS method performance
The analytical method for the determination of steroid
esters in hair is described by Nielen [23]. The method was
in-house-validated according to EU legislation 2002/657/
EC [31] for 13 steroid esters—including EB, TC and TD.
The validation was performed according to the guidelines
for a confirmatory method. The CCα and CCβ were
determined by the analysis of 20 different samples of hair
with and without addition of steroid esters. The CCα of EB,
TC and TD were respectively 2, 6 and 6 µg/kg. The CCβ of
EB, TC and TD were respectively 5, 20 and 20 µg/kg.
Recent publications [24, 32] demonstrate that the method is
suitable for the analysis of steroid esters in bovine hair. To
use the method as a quantitative method, some additional
validation was performed. The linearity of the calibration
curve was checked within the range of 2.5–250 µg/kg for
EB and of 10–1,000 µg/kg for TC and TD. The coefficient
of correlation (R2) was better than 0.98 for all tested esters.
The within-lab reproducibility was determined at the CCβ
concentration level. In different sample series (analysed on
different days), a (blank) sample fortified at CCβ level was
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analysed. The %RSD was 20, 5 and 20% (n=9) for EB, TC
and TD, respectively.
For this study—determination of the kinetics of the
elimination—the obtained results from method validation
are adequate. The CCβ-s are at or below 20 µg/kg, linearity
is better than 0.98. Furthermore, deuterated internal stand-
ards are available for each steroid-ester to correct for
recovery losses and the influence of the matrix resulting in
within-lab reproducibility results of %RSD <25%.
Steroid esters in hair
Figures 2–6 present the concentration of the steroid esters
measured in the samples of hair. The vertical lines at day 35
(after 5 weeks) divided the plot into samples of hair grown
for 8–12 weeks and samples grown for only 5 weeks (see
also Fig. 1 and Table 4). The horizontal lines in the figures
represent the CCβ-s of the steroid esters measured.
Figure 2a represents the results of the animal injected once
with the hormone cocktail and Fig. 2b represents the results
of the repeated i.m. injection treatment. The treatment took
place on days 1, 7 and 14. Note that the concentration scale
is a logarithmic scale.
The results obtained after pour-on treatment are
presented in the Figs. 3–6. The treatments presented in
Figs. 3–6 differ only in the carrier solvent used DEGMBE,
DMSO, IVOMEC or Miglyol. Figures 3a–6a present the
single-treatment results and the Figs. 3b,–6b the repeated
pour-on treatment results.
For monitoring the illegal use of steroid esters the CCβ
concentration is most relevant because at and above that
concentration, identification according to the EU criteria is
Animal no. 174 (injection steroid-esters 1x)
1
10
100
1000
10000
7 14 21 28 35 42 49 56 63 70 77 84 91
Days after first treatment
Co
nc
. (µ
g/k
g)
estradiolbenzoate
testosteronecypionate
testosteronedecanoate
CCβ EB = 5 µg/kg →
CCβ TC, TD  = 20 µg/kg  →
a
Animal no. 171 (injection steroid-esters 3x)
1
10
100
1000
10000
7 14 21 28 35 42 49 56 63 70 77 84 91
Days after first treatment
Co
nc
. (µ
g/k
g)
estradiolbenzoate
testosteronecypionate
testosteronedecanoate
CCβ EB = 5 µg/kg →
CCβ TC, TD  = 20 µg/kg  →
b
Fig. 2 Concentration of the steroid esters found in hair samples after
intramuscular injection
Animal no. 178 (steroid-esters in DEGMBE 1x)
1
10
100
1000
10000
7 14 21 28 35 42 49 56 63 70 77 84 91
Days after first treatment
Co
nc
. (µ
g/k
g)
estradiolbenzoate
testosteronecypionate
testosteronedecanoate
CCβ EB = 5 µg/kg →
CCβ TC, TD  = 20 µg/kg  →
a 
Animal no. 179 (steroid-esters in DEGMBE 3x)
1
10
100
1000
10000
7 14 21 28 35 42 49 56 63 70 77 84 91
Days after first treatment
Co
nc
. (µ
g/k
g)
estradiolbenzoate
testosteronecypionate
testosteronedecanoate
CCβ EB = 5 µg/kg →
CCβ TC, TD  = 20 µg/kg →
b 
Fig. 3 Concentration of the steroid esters found in hair samples after
pour-on treatment
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possible in at least 95% of all non-compliant cases. For this
study, it is important to establish how long after treatment
the CCβ concentration level is reached; in other words,
how long after treatment the hair sample is ‘non-compli-
ant’. All results are based on single-hair analysis. When no
recovery of the internal standard was measured and/or
when too many interfering peaks were measured, the
quantification was not possible for the specific analyte/
sample combination. These data are the missing points in
the figures. The missing points at the higher concentration
levels are mostly due to low recovery of the internal
standards. The used method fits the purpose; however, due
to the different sample pre-treatment steps necessary
(pulverising, digestion, SPE), the absolute recovery is
sometimes low. When the internal standard is not detected,
the quantification is not possible. The missing points at or
below the CCβ levels are, for most samples, due to
observed interfering peaks most probably due to residues
of some fatty compounds like sebum.
From the results presented in Figs. 2–6 some general
conclusions can be drawn.
The maximum concentrations measured for all applica-
tions (pour-on and injection) are for TC with a maximum of
9,600 µg/kg by pour-on application in DMSO. In general,
the TC concentrations are slightly higher than the TD
concentration. Due to the concentrations applied EB shows
the lowest concentrations in hair.
Table 5 presents how many days after treatment the CCβ
concentration (lowest concentration resulting in ‘non-
compliant’ results) levels are reached. In general, for single
treatment, the CCβ levels are reached after 35–49 days
with the only exception of the pour-on application in
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Fig. 4 Concentration of the steroid esters found in hair samples after
pour-on treatment
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Fig. 5 Concentration of the steroid esters found in hair samples after
pour-on treatment
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DEGMBE for which the CCβ levels are reached after
>56 days (8 weeks) after treatment. For the pour-on
application in Miglyol, some relevant data points are
missing but by extrapolating the elimination plot for TC it
is expected that the CCβ is reached between 56 and 63 days
after treatment.
For repeated treatment, the following conclusions can be
drawn: it is obvious that the highest concentration levels of
steroid esters are reached after the first treatment and that
there is hardly any concentration differences between
injection and pour-on application. The maximum elimina-
tion rate of steroid esters into the hair is probably reached
already after the first treatment and so, additional treatments
do not result in higher concentrations levels in the hair
samples. The number of treatments do not have effect on
the maximum concentration level in hair but on the number
of days the concentrations are at a high level (>1,000 µg/kg).
Consequently, after repeated treatment, it takes more time
before the CCβ levels are reached. By repeated treatment,
the high level is (in comparison with the single treatment)
continued for 21–28 days then the concentrations started to
decrease. For TC, the CCβ level is reached for all
application after >91 days. The only exception is the pour-
on application in IVOMEC for which TC reached the CCβ
level after 43 days but these results are not very reliable
because—rather unexpected—the TC concentration started
to increase after 63 days. For the steroid esters EB and TD,
the CCβ levels are reached at 63–77 days (9–11 weeks) after
injection or pour-on treatment with the carrier solvent
DMSO or IVOMEC. For the pour-on application in
DEGMBE and Miglyol, slightly longer elimination times
for EB and TD viz. 77–84 days (11–12 weeks) are observed.
It is difficult to draw conclusions about the comparison
of injection and pour-on application. Only two animals were
injected with the hormone cocktail. This experiment—in
which one animal was injected once and one animal was
injected three times—shows that the steroid ester concen-
trations in the hair samples collected after injection were
roughly at the same level as after pour-on treatment. It seems
that the application procedure does not affect the steroid ester
elimination rate into the hair.
Note that the samples of hair collected before treatment
(t=0 samples) did not contain any of the steroid esters at
detectable concentrations. Based on the results obtained, it
was decided not to analyse all the hair samples collected
from the animals treated with only carrier solvent or
untreated (reference group) animals. From these treatments,
only the samples taken at week 0, 5, 10, and 14 were
analysed. The samples did not contain any of the steroid
esters at a detectable concentration.
Importantly, the sample of hair collected during the
contamination (carry-over) experiment did not contain any
of the steroid esters at a detectable concentration.
Determination of steroid esters in plasma by LC-MS/MS
A method was set up to monitor steroid esters in plasma.
From literature, it is known that after application of 135 mg
testosterone esters to a human body, the blood concen-
trations after 96 h is about 1 µg/l [29]. For that reason, the
method was set up in the concentration range of 0–10 µg/l.
The method was validated for qualitative analyses only but
to each sample, the internal standards were added and the
recovery of the internal standards (criteria S/N of internal
standard has to be >3) was used as a sensitivity and
recovery check. The lowest calibration point was at 1 µg/l and
therefore the LOD was set for all steroid esters at this specific
concentration level. All samples of plasma collected from the
animals treated once and three times (injection and pour-on)
with the hormone cocktail were analysed for containing
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Fig. 6 Concentration of the steroid esters found in hair samples after
pour-on treatment
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steroid esters. In none of the samples detectable concen-
trations (> LOD) of steroid esters were monitored
As mentioned above, the method was partially validated
and for that reason a selection of the plasma samples was
send to the EU Community Reference Laboratory for
hormones the RIVM (Bilthoven, the Netherlands) and were
analysed under ISO/NEN 17025 accredited conditions for
containing steroid esters. The sub selection consists of the
following samples: plasma collected from Days 0 to 42 of
the animal injected (3×), Days 0 to 14 of the animal
injected 1× and the first five samples collected after pour-
on application (1× and 3×) by using DEGMBE as the
carrier solvent. Again, no steroid esters were detected. The
LOD levels for EB, TC and TD for the LC-MS/MS method
used were 0.2, 0.3 and 1 µg/l, respectively. That no steroid
esters were detected in the plasma samples was not
completely unexpected. Shackleton [29] already described
that after application of 135 mg of testosterone esters to a
human body the blood concentrations after 96 h is about
1 µg/l. In other words, rapid hydrolysis of steroid esters takes
place as soon as the steroid esters reach the bloodstream.
Determination of free steroids in plasma by GC-MS/MS
GC-MS/MS method performance
The analytical method for the determination of free steroids
in plasma and the validation of the method are described by
van Tricht et al. [30]. The method was validated according
to EU legislation 2002/657/EC [31] for 20 natural
hormones—including 17α-, 17β-estradiol and 17α-, 17β-
testosterone. For this study, the linearity of the calibration
curve was checked for the 0–400 ng/l range. The coefficient
of correlation (R2) was better than 0.98. A summary of the
method validation results is presented in Table 6. The
measurement uncertainties based on within-laboratory-
reproducibility (n=21) are for 17α- and 17β-estradiol 25
and 20%, respectively, and for 17α- and 17β-testosterone
40 and 46%, respectively.
For this study—determination of the kinetics of the
elimination—the obtained results for method validation are
adequate. The CCβ levels are at or below 16 ng/l for estradiol
and 50 ng/l for testosterone, linearity is better than 0.98. The
detection limits of this method are low enough to measure the
concentration of natural hormones (endogenous hormones) in
plasma. Furthermore, deuterated internal standards are
available for each steroid to correct for recovery losses and
the influence of the matrix. Although the observed uncer-
tainties in the measurements of the free testosterone are
relatively high, the method was useful for the determination
of the elimination kinetic. The testosterone measurement
showed high variability during this study, probably due to
natural variation of testosterone concentrations.
Free steroids in plasma GC-MS/MS results
A selection of the plasma samples were analysed for 17α-,
17β-estradiol and 17α-, 17β-testosterone. The samples
analysed were the samples collected from the animal
injected with the hormone cocktail (1× and 3×). Injection
is a traditional way of treating the animal with steroid
esters. It is of interest to analyse the plasma samples
collected after injection of the hormone cocktail and to
compare the results with the results of the pour-on
application. Since, only minor differences were observed
in the steroid ester concentration of hair samples by using
different carrier solvents for pour-on application, it was
Table 6 Validation paramaters for the GC-MS/MS analysis of
steroids in plasma; adapted from [30]
Compound CCα (in ng/l) CCβ (in ng/l)
17α-estradiol 9 16
17β-estradiol 7 12
17α-testosterone 20 40
17β-testosterone 30 50
Injection Pour-on application
DEGMBE DMSO IVOMEC Miglyol
Single treatment
Estradiol benzoate 35–42 56–63 42–49 35–42 35–42
Testosterone cypionate 49–56 70–77 49–56 35–42 >56
Testosterone decanoate 42–49 56–63 49–56 49–53 >49
Repeated treatment
Estradiol benzoate 63–70 77–84 70–77 63–70 77–84
Testosterone cypionate >91 >91 >91 42–49a >91
Testosterone decanoate 70–77 84–91 70–77 77–84 84–91
Table 5 Number of days after
treatment the CCβ concentration
levels are reached
a Unreliable results; concentra-
tion increases significantly after
63 days
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decided to analyse only one set of the plasma samples after
pour-on application. For the analysis, the samples collected
after pour-on application of the hormone cocktail with the
carrier solvent DEGMBE (1× and 3×) were selected. These
samples were selected because the corresponding hair
samples contained the relatively high levels of steroid
esters. Possibly, these high levels would correspond with
high plasma levels resulting in detectable concentrations
(above CCβ).
Figures 7 and 8 present the results obtained for the
analysis of 17α-, 17β-estradiol and 17α-, 17β-testosterone
in plasma samples. In Fig. 7, the results for ‘injection’ and
in Fig. 8 the results for ‘pour-on’ are presented. Figures 7a
and 8a are results obtained after single treatment; Figs. 7b
and 8b are results obtained after repeated treatment. Note
the non-linear time axis. The first plasma samples were
collected just before the first treatment (Day 0) followed by
1, 2, 3, 4, 5 and 6 days after treatment. The next samples
were collected at day 14, 21, 28 (2, 3 and 4 weeks after the
first treatment) and at day 42, 56, 70, and 98 days (6, 8, 10
and 14 weeks after treatment). Samples taken at day 14 and
day 21 were collected before the second and third treat-
ments took place. When no recovery of the internal
standard was measured and/or when too many interfering
peaks were measured, the quantification was not possible
for the specific analyte/sample combination. These data are
the missing points in the figures. Especially around the
CCβ levels, data points are missing due to some interfering
peaks in these specific samples. Additional research is
necessary to improve the robustness of the method.
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Fig. 7 Concentration of free steroids found in plasma after intramus-
cular injection
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Fig. 8 Concentration of free steroids found in plasma samples after
pour-on treatment
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Although it is difficult to draw conclusions based on one
data set for injection and one data set for pour-on, some
observations are worthwhile to mention. It is obvious that
the concentration of the free steroids in plasma after
injection is significantly higher than the concentrations of
free steroids after pour-on application. It is of interest to see
that after injection (Fig. 7b), the highest levels of free
steroids are measured between 1 and 3 days after the first
treatment and that the maximum concentrations reached for
the 17β-forms are between 1,000 and 2,000 ng/l and for the
17α-forms are much lower, viz. 100 ng/kg. For the pour-on
application (Fig. 8b), the highest levels of free steroids are
also measured between 1 and 3 days after the first
treatment, however, for this application, the maximum
concentrations reached are much lower (maximum of
410 ng/l for 17β-testosterone). A second remarkable
difference between injection and pour-on results is that for
the pour-on application, there is no significant difference in
maximum concentrations for the four steroids determined. In
other words, the maxima reached for 17α-, 17β-estradiol
and 17α-, 17β-testosterone are within the small range of
200–400 ng/l—in contrast, for injection, 17β-concentrations
are approximately ten times higher than 17α-concentrations.
Regarding the steroid elimination time, it is clear that
5 days after repeated injection (Fig. 7b), the steroid
concentrations are still above CCβ levels. Due to the second
injection at Day 7 and the third injection at Day 14, the
concentrations of the free steroids are higher than the ‘t=0
concentration’ even after Day 6. It has to be mentioned that
the elimination time is defined as the time it takes to reach the
concentration of less than or equal to CCβ or to reach the
‘t=0 concentration’ in case of a natural occurring background
for example for 17α-estradiol and/or 17α-testosterone.
Regarding the steroid elimination time after the pour-on
application, it is concluded that the CCβ or ‘t=0 concen-
trations’ are reached within 5 days after the first applica-
tion. No increase of steroid concentration is monitored after
the second and third applications. The 17α-testosterone
concentrations measured at day 42 and day 98 in Fig. 8a are
probably outliers due to some interfering compounds. The
results are not confirmed in Fig. 8b. It is possible that there
is an increase of free steroid concentrations after the second
and third applications (Fig. 8b) but due to the sample
collection scheme, the possible increases were not moni-
tored. The increase of free steroid concentration is expected
in the samples collected 1–3 days after application; in this
study, in the samples of Day 8, 9 and 10 and Day 15, 16
and 17, but, unfortunately, no samples were collected at
these specific times.
From pharmokinetic experiments, it is known that the
steroid esters when entering the bloodstream are hydrolysed
to the free steroids viz. 17β-testosterone and 17β-estradiol.
Furthermore, before elimination, free steroids are epimer-
ized to α-testosterone and α-estradiol. C17 epimerization is
a major pathway for steroids. This is also confirmed by the
elimination kinetic described by Pinel [33]. In [33], it is
demonstrated that the main metabolites detected in urine
after i.m. injection of 17β-estradiol benzoate and 17β-
nortestosterone laureate are 17α-estradiol and 17α-
nortestosterone.
From the results obtained for the concentration of the free
steroids in the present study, it is concluded that after i.m.
injection, high concentrations of β-steroid esters enter the
blood and are quickly hydrolysed to their free form—17β-
testosterone and17β-estradiol—and after epimerization to the
free 17α-steroids. However, after pour-on application, the
concentrations of freeβ-steroids are much lower probably due
to the fact that not all steroid esters enter the blood. It is
possible that after pour-on application, the transport of the
steroid esters to the hair is by another route than by blood
transport, e.g. other extravascular or interstitial fluids [26]. So
after pour-on application, the steroid esters are already
hydrolysed, epimerized and eliminated before entering the
blood resulting in much lower concentrations of the free β-
steroids. After i.m. injection, the steroid esters enters the
blood very quickly are hydrolyzed to the free β-steroids
which are detected in the first 5 days after injection.
Conclusions
From the animal trial performed by i.m injection and pour-
on application of steroid esters using different carrier
solvents, it is concluded that: no significant differences
are observed between the elimination rate of steroid esters
in hair after i.m. injection and pour-on application of steroid
esters. For both ways of application, the concentrations of
steroid esters reach the CCβ levels (5–20 µg/kg) 5–7 weeks
after single treatment and 9–11 weeks after repeated (three
times) treatment. The identity of the carrier solvent during
pour-on application does not have significant influence on
the final steroid ester concentration in hair.
Even though high concentrations of steroid esters are
measured in hair, no detectable concentration of steroid
esters (<1 µg/l) were measured in the plasma of the treated
animal. This is probably due to the quick hydrolysis of
steroid esters to free steroids.
The only difference in i.m. injection and pour-on
application measured in this study is the concentration of
free β-form steroids in plasma. The concentration of free β-
form steroids measured in plasma are much higher (ten
times reaching 2,000 ng/l) after injection than after pour-on
treatment. The concentrations of the α-form steroids are not
significantly different. From these results, it is supposed
that after the pour-on treatment, the transport of steroid
esters to the hair is not only by blood but also by other
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fluids. In this way, steroid esters are already hydrolysed,
epimerized and eliminated before reaching the blood
resulting in low concentration of the free steroids in plasma
after pour-on application.
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